The usefulness of glutathione for the treatment of NAFLD: a pilot study
Not Applicable
Not yet recruiting
- Conditions
- onalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000011118
- Lead Sponsor
- Japan Study Group of NAFLD (JSG-NAFLD)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
decompensated cirrhosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT
- Secondary Outcome Measures
Name Time Method steatosis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glutathione's therapeutic effects on nonalcoholic fatty liver disease (NAFLD)?
How does glutathione compare to standard-of-care treatments for NAFLD in terms of efficacy and safety?
Are there specific biomarkers that can predict patient response to glutathione therapy in NAFLD?
What are the potential adverse events associated with glutathione treatment in NAFLD patients and how are they managed?
What related compounds or combination therapies are being explored alongside glutathione for NAFLD treatment?